<?xml version="1.0" encoding="UTF-8"?>
<p>Among the flavonoid-based compounds, only quercetin is undergoing clinical trial due to its anti-inflammatory and scavenging activity. In detail, its dose scheduled is 500â€“1000 mg for prophylaxis and treatment, respectively [
 <xref rid="B78-molecules-26-00632" ref-type="bibr">78</xref>].
</p>
